Skip to main content
. 2014 Jun 12;26(3):363–373. doi: 10.5021/ad.2014.26.3.363

Fig. 4.

Fig. 4

Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) protein and mRNA in SK-MEL-2 and SK-MEL-24 cell lines following treatment with imiquimod. Expression of MT1-MMP proteins in SK-MEL-2 (A) and SK-MEL-24 (B) cell lines was dose-dependently decreased with increasing concentrations of imiquimod. Relative mRNA expression of MT1-MMP in SK-MEL-2 (C) and SK-MEL-24 (D) cell lines, following treatment with a range of imiquimod concentrations (5, 10, 30 µg/ml), compared to controls (0 µg/ml). Con A: concanavalin A. *p<0.05 vs. control.